Depression Treatment Market Trends, Future Outlook, Growth, Analysis and Forecast 2023-2029

The global depression treatment Market is anticipated to grow at a CAGR of 4.1% during the forecast period. The increasing number of FDA approvals for antidepressants along with the expansion in pipeline products by key market players is certain factors driving the growth of the depression treatment industry.

In February 2021, Zydus Cadila has received US FDA approval for Nortriptyline Hydrochloride Capsules USP. The capsules come up in the strength of 10 mg, 25 mg, 50 mg, and 75 mg. Nortriptyline Hydrochloride Capsules USP is majorly used for the treatment of depression.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/depression-treatment-market

Moreover, in July 2020, VistaGen Therapeutics, a US-based biopharmaceutical company had received US FDA approval for PH94B under Phase 3 development to treat acute anxiety and mental illness in adult patients with a social anxiety disorder (SAD). PH94B is an investigational rapid-onset neurosteroid nasal spray majorly used for the treatment of social anxiety disorder.

Furthermore, in March 2019, Johnson & Johnson's ketamine-derived nasal spray Spravato for treatment-resistant depression has been approved by the FDA. The Spravato CIII Nasal Spray is used for the treatment of depressive disorder in adults with a high risk of major depressive disorder (MDD). Thus, these approvals by the FDA for antidepressant drugs produced by major key players, the depression treatment market is expected to witness significant growth during the forecast period.

Market Coverage

The market number available for - 2021-2027
Base year- 2020
Forecast period- 2021-2027
Segment Covered-
o By Drug Type

Regions Covered-
o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Eli Lilly and Company, Pfizer, Inc., Johnson & Johnson, Merck & Co., Inc., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd, and Others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Depression Treatment Market Report Segment

By Drug Type

Selective Serotonin Reuptake Inhibitors
Tricyclic Antidepressants
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Others

A full report of Depression Treatment Market is available at: https://www.omrglobal.com/industry-reports/depression-treatment-market

Depression Treatment Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Alkermes Plc
Allergen Plc
AstraZeneca plc
Bausch Health Companies, Inc.
Eli Lilly and Co.
Hoffmann-La Roche AG
Garmin Ltd.
GlaxoSmithKline plc
Lundbeck A/S
Johnson & Johnson Services, Inc.
Lief Therapeutics
Lupin Ltd.
MagVenture, Inc.
Mylan N.V.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/%ec%bc%80%ec%9d%b4%eb%b8%94-%eb%aa%a8%eb%8e%80-%ec%a2%85%eb%8b%a8-%ec%8b%9c%ec%8a%a4%ed%85%9c-%ec%8b%9c%ec%9e%a5-%ea%b7%9c%eb%aa%a8-%ec%a0%90%ec%9c%a0%ec%9c%a8-%ec%9d%b8%ec%83%81%ec%a0%81%ec%9d%b8/46783/

https://www.asiatimeskorea.com/press-release/%ea%b1%b4%ec%84%a4-%eb%a1%9c%eb%b4%87-%ec%8b%9c%ec%9e%a5-%ec%a0%90%ec%9c%a0%ec%9c%a8-2023-%eb%8f%99%ed%96%a5-%ec%a3%bc%ec%9a%94-%ec%97%85%ec%b2%b4-%ec%82%b0%ec%97%85-%eb%b6%84%ec%84%9d-%eb%b0%8f/411325/

https://monblogapple.com/2023/03/24/croissance-du-marche-du-stockage-en-reseau-grand-public-rapport-danalyse-tendances-et-apercu-2023-2029/

https://revistaeconomiasocial.com/2023/03/24/contact-center-analytics-tendencias-del-mercado-informe-de-investigacion-crecimiento-oportunidades-pronostico-2023-2029/

https://sportmsr.com/%d8%aa%d9%82%d8%b1%d9%8a%d8%b1-%d8%b3%d9%88%d9%82-%d8%aa%d8%b5%d9%86%d9%8a%d8%b9-%d8%b9%d9%82%d9%88%d8%af-%d8%a7%d9%84%d8%b3%d9%8a%d8%a7%d8%b1%d8%a7%d8%aa-2023-%d8%ad%d8%b3%d8%a8-%d8%a7%d9%84%d9%84-2/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.